News
Following a lengthy public meeting Tuesday, the Utah County Planning Commission voted 5-1 to withhold a decision on PacifiCorp’s application for a conditional use permit to build a 345-kilovolt, ...
Emergency telephone lines are once again operational after being offline all day because of “technical difficulties”. The Bermuda Police Service said that the emergency 911 line and the non-emergency ...
The government has estimated sugar stock at end of August at about 69 lakh tonnes (lt) and allocated 23.5 lt for domestic sales during September. As the Dussehra and Diwali festivals will be ...
One of the most annoying features in Windows 11/10 for desktop computers is the sleep timeout, which is the time period after which your computer enters energy-saving sleep mode. This time period can ...
The Review of Economics and Statistics Vol. 72, No. 1, Feb., 1990 The Inappropriate use of Serial Correlation Tests in Dynamic Linear Models This is the metadata section. Skip to content viewer ...
Daniel Liberto is a journalist with over 10 years of experience working with publications such as the Financial Times, The Independent, and Investors Chronicle. Amy is an ACA and the CEO and founder ...
Exelixis’ (EXEL) lead drug, Cabometyx, a tyrosine kinase inhibitor (TKI), is one of the leading drugs for the treatment of renal cell carcinoma (RCC). The FDA approval for the label expansion of ...
Thomas J Catalano is a CFP and Registered Investment Adviser with the state of South Carolina, where he launched his own financial advisory firm in 2018. Thomas' experience gives him expertise in a ...
Takeda and Seattle Genetics are closing in on a new front-line use for their Adcetris in classical Hodgkin lymphoma after a successful late-stage trial. The positive results from the phase 3 ECHELON-1 ...
Energy Fuels UUUU has reached a significant milestone by producing the first kilogram of dysprosium (Dy) oxide at pilot scale from its White Mesa Mill in Utah. The company exceeded expectations by ...
Hosted on MSN18d
Will Camzyos Strengthen BMY's Cardiovascular Portfolio?
Bristol Myers’ (BMY) cardiovascular portfolio currently comprises blockbuster drugs Eliquis and Camzyos. Blood thinner medicine Eliquis, for which BMY has a worldwide co-development and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results